Legend Biotech Corporation (LEGN) Description, Stock price, News & Info

#ThinkSabio Latest News

LEGN – Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)